Response Biomedical Corp.: federal grants and contributions

Updated 12 October 2026 · Vancouver|Vancouver, BC · grants and contributions register · Vancouver Quadra

Response Biomedical Corp.: federal grants and contributions: 18 agreements; $2.5M value; 1 departments; 4 programs.

Assay record ASY-CA-1BCBSKV06B · Cite as: Assay Systems, “Response Biomedical Corp.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/response-biomedical-corp/

$
18agreements
$2.5Mvalue
1departments
4programs

Largest agreements

COVID-19 - Development of a RAMP COVID-19 Antigen Assay$551Kvalue2020start2022end

This project is designed to support the current COVID-19 pandemic by producing a high quality 15 minute RAMP COVID-19 Antigen test. The RAMP platform is based on fluorescence detection & has demonstrated similar performance to PCR in end user settings.

Agreement$372Kvalue2017start–end
COVID-19 - Feasibility of a RAMP Multiplex Assay Format$317Kvalue2023start2023end

Covid-19 - Feasibility of a RAMP Multiplex Assay Format

Development of a new RAMP Reader with Associated hCG Test$279Kvalue2017start2019end

The aim of this project is to develop a new RAMP Point-of-Care reader system and associated hCG test that will enable Response Biomedical to successfully increase market share by expanding sites of use and improving access to developing markets.

Business Innovation – Increasing Lead Generation and In Vitro Diagnostic Test Product Sales Revenues in the United States and Canada.$250Kvalue2023start2024end

Business Innovation – Increasing Lead Generation and In Vitro Diagnostic Test Product Sales Revenues in the United States and Canada.

Development of a Multiplex Diagnostic Test with Acute Care Panel$215Kvalue2024start2025end

Development of a Multiplex Diagnostic Test with Acute Care Panel

COVID-19 Response - Development of a RAMP COVID-19 Serological Assay$170Kvalue2020start2021end

This project is designed to support Canada (and global partners) with the current COVID-19 pandemic by producing a high quality 15 minute RAMP COVID-19 serological test. The RAMP platform is based on fluorescence detection & has demonstrated similar performance to PCR in end user settings.

Elizabeth$40.0Kvalue2018start2019end

Our goal to strengthen and expand our IVD distribution channels within the European market, focusing on the United Kingdom, the 6th largest market globally.

Show all 18
Agreement$38.0Kvalue2017start–end
Response Biomedical Corp - 2020-2021 - 962956$35.2Kvalue2020start2021end

The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.

Response Biomedical Corp.-2025-2026-1037059$32.5Kvalue2025start2026end

The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.

Alpide Belt$30.5Kvalue2019start2019end

Response's goal to strengthen and expand our IVD distribution channels within the Asia Pacific, South Asia, and African markets, focusing on India, Thailand, Myanmar, and South Africa.

Response Biomedical Corp.-2022-2023-993809$30.0Kvalue2022start2023end

The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.

Response Biomedical Corp.-2023-2024-1012563$30.0Kvalue2023start2024end

The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.

Response Biomedical Corp.-2024-2025-1022824$23.0Kvalue2024start2025end

The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.

LATAM Expansion$22.5Kvalue2020start2020end

Response's goal is to strengthen and expand our IVD distribution channels within the Latin American markets, focusing on Costa Rica, Guatemala, Panama, Uruguay and El Salvador.

Response Biomedical Corp.-2026-2027-1044054$19.1Kvalue2026start2026end

The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.

Response Biomedical Corp-2021-2022-984985$15.0Kvalue2021start2022end

The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.

Departments

National Research Council Canada18agreements$2.5Mvalue4programs
  • Industrial Research Assistance Program – Contributions to Firms
  • CanExport SMEs
  • CanExport
  • CanExport SME

All grants from National Research Council Canada

Years

20261agreements$19.1Kvalue1programs
  • CanExport
20251agreements$32.5Kvalue1programs
  • CanExport SME
20242agreements$238Kvalue2programs
  • Industrial Research Assistance Program – Contributions to Firms
  • CanExport SME
20233agreements$597Kvalue2programs
  • Industrial Research Assistance Program – Contributions to Firms
  • CanExport SME
20221agreements$30.0Kvalue1programs
  • CanExport SMEs
20211agreements$15.0Kvalue1programs
  • CanExport SMEs
20204agreements$779Kvalue2programs
  • Industrial Research Assistance Program – Contributions to Firms
  • CanExport SMEs
20191agreements$30.5Kvalue1programs
  • CanExport
20181agreements$40.0Kvalue1programs
  • CanExport
20173agreements$689Kvalue1programs
  • Industrial Research Assistance Program – Contributions to Firms

Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.